Clinical Trials Directory

Trials / Completed

CompletedNCT05972109

Metabolic Health Improvement Program: Effects of a Workplace Sugary Beverages Sales Ban and Motivational Counseling

Multi-Level Trial of a Workplace Sales Ban of Sugary Beverages and Brief Motivational Counseling Intervention on Adiposity

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
604 (actual)
Sponsor
University of California, San Francisco · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

The purpose of the study is to test the impact of a multilevel workplace intervention (hospital-wide sales ban on sugar-sweetened beverages (SSBs) and individual-level brief counseling) on employee health.

Detailed description

This double-randomized controlled trial of a multilevel workplace intervention that combines an employer-sponsored sales ban on sugar-sweetened beverages (SSBs) with brief counseling to support reduced consumption will test how well each intervention works alone, whether they work better in combination than separately, and whether or not changes in SSB cravings mediate these effects. Sutter Health worksites will be randomly assigned to either a control condition or to implement a sales ban on SSBs. Within all sites, employees will be randomized to receive/not receive a brief counseling intervention focused on reducing SSB consumption. Participants will complete self-report questionnaires, give blood samples, and provide measurements of waist circumference, height, and weight. These data will be analyzed to determine the effects of the interventions, both separately and in combination.

Conditions

Interventions

TypeNameDescription
OTHERWorkplace SSB sales banEnvironmental Intervention. The hospital food services will replace sugary drinks with non-sugar added alternative beverages throughout the campus.
BEHAVIORALBrief InterventionParticipants receive single-session brief intervention, which is an intervention that uses motivational interviewing, and helps participants understand amount and effect of their baseline SSB intake, identify realistic goals for reduction and overcoming obstacles.

Timeline

Start date
2023-08-01
Primary completion
2025-12-01
Completion
2026-02-01
First posted
2023-08-02
Last updated
2026-02-23

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT05972109. Inclusion in this directory is not an endorsement.